Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types.

Vasu Research Centre0 个研究点目标入组 24 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Voluntary men and women ration of 1:1 between 18 and 65 years.
•Having healthy skin on test area as assessed by dermatological examination.
•For whom the investigator considers that the compliance will be correct.
•Subjects with normal, dry, oily and combination skin
•Subjects cooperating informed of the need and duration of the examination and ready to comply with protocol procedures.
•Having a signed consent form.
•SubjectsÃ¢â?¬• willingness to avoid intense UV exposure on test site (sun or artificial UV), during the study.
•Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna Ã¢â?¬Â¦.), during the study.
•Having valid proof of identity and age.
•Volunteers evaluated with Fitzpatrick skin type 3 to 5 as per the Fitzpatrick scale (Appendix IV).

•Pregnant/nursing mothers.
•Scars, excessive terminal hair, or tattoo on the studied area.
•Dermatological infection/pathology on level of studied area.
•Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)
•Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.
•Ã¢â???Chronic illness which may influence the outcome of the study.
•Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
•Subject in an exclusion period or participating in another food, cosmetic, or therapeutic trial.
•Volunteers evaluated with Fitzpatrick skin type 1,2 and 6 as per the Fitzpatrick scale (Appendix IV).

发起方

Vasu Research Centre